2016 annual financial data
Karyopharm Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -54,799.35%.
Operating income was -110,732,000 USD and net income was -109,577,000 USD.
Operating cash flow was -84,391,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,000 USD
- Operating income
- -110,732,000 USD
- Net income
- -109,577,000 USD
- Operating cash flow
- -84,391,000 USD